EFFIX PHARMA AS

Signals

3 flags

• ▼ Negativ egenkapital 2025 Bokført egenkapital er negativ (−4,1 mill kr).
• ▼ Driftsunderskudd 2025 Siste driftsresultat er negativt (−22k kr).
• ◎ Ingen revisor Selskapet har ingen registrert revisor. Vanlig for små AS som har valgt bort revisjon, men verdt å merke seg.

EFFIX PHARMA AS is registered as a limited company in Randaberg, Rogaland with organisation number 992559055. The business is classified under research and experimental development on natural sciences and engineering (NACE 72.100). The company was incorporated in 2008. Registered share capital is NOK 100,000, divided into 1000 shares. The company's stated purpose is: “Å utvikle medisiner og kosttilskudd, samt delta som eier i selskaper som driver med tilsvarende virksomhet.”. The most recent filed accounts, for the 2025 financial year, show NOK 0 in revenue and NOK −22,000 in operating profit.

Key figures · 2025

Revenue

NOK 0

Operating profit

NOK −22,000

Equity

NOK −4.1m

Financial health · 2025

Liquidity

0.04

Not satisfactory

Current assets ÷ current liabilities

Profitability

–

Not available

Return on total assets

Solidity

-16390.8%

Weak

Equity as a share of total capital

Solidity capped at Weak because equity is below NOK 100,000.

Who owns EFFIX PHARMA AS?

CAPTROL AS

100.0%

EFFIX PHARMA AS

NOK 0 rev. · NOK −22,000 profit

EFFIX PHARMA AS has 1 registered shareholder:

• CAPTROL AS 100.0%

All shareholders and roles →

Frequently asked questions about EFFIX PHARMA AS

Who owns EFFIX PHARMA AS?

CAPTROL AS is the largest registered owner, with 100.0%.

What is the revenue of EFFIX PHARMA AS?

EFFIX PHARMA AS had revenue of NOK 0 in 2025.

Where is EFFIX PHARMA AS based?

EFFIX PHARMA AS has its business address in Randaberg.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.